Urgo Recherche Innovation Et Developpement

Laboratoires Urgo

Societe De Developpement Et De Recherche Industrielle

Laboratories Urgo

Centre National De La Recherche Scientifique

Université D'evry-Val-D'essonne

Centre D'etude Des Cellules Souches

Adhara

Christelle Laurensou

Laurent Apert

Jean-Marc Pernot

Pierre Schaaf

Stéphane Auguste

Stephane Auguste

Marielle Bouschbacher

Fouzia Boulmedais

Sandra Rodrigues

Sylvain Mery

Jean Guzzo

Patrice Arbault

Nicolas Desroche

Dominque Nicot

Christine Baldeshi

Sophie Clement

Guillaume Olive

Dominique Nicot

The present invention relates to the use, as an agent for salting out an active substance in a composition for a dressing, of a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulphonic acid and the 2-hydroxyethyl ester of propenoic acid. It also relates to dressings of the type comprising at least one fatty substance and/or an elastomeric matrix and at least one active substance, which incorporate the aforementioned copolymer.

Agent for salting out active principles in dressings containing at least one of fatty substance

The subject matter of the present invention is a bacterium or a mixture of bacteria having an antagonistic activity with respect to strains ofand/oras well as the use thereof in the treatment and/or prevention of infections or colonizations related to those pathogens. The invention pertains to care products containing one or more non-pathogenic antagonistic strains intended to prevent and/or treat infections or colonizations on skin, wounds, mucous membranes and appendages.

Method for preventing and/or treating infections, colonisations, or illnesses related toand/or

One subject of the present invention is a dressing essentially consisting of: This product is especially intended to promote the healing of chronic wounds by optimizing the debridement.

Absorbent cicatrization dressing and uses thereof for chronic wounds

The present invention relates to a compound selected among the synthetic polysulphated oligosaccharides having 1 to 4 ose units and the salts and complexes thereof to be used for the treatment of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars. Said use is preferred in particular in patients that have a predisposition to developing hypertrophic, retractile or atrophic scars. According to a second aspect, the invention also relates to said compound for the use thereof in order to inhibit the differentiation of fibroblasts into myofibroblasts during the cicatrisation of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars.

Use of oligosaccharide compounds for the prevention and treatment of pathological scars

The present invention relates to the use of at least one compound selected among the synthetic polysulphated oligosaccharides having 1 to 4 ose units and to the salts and complexes thereof as cleaning agents for a wound. The invention can be used in particular for preparing bandages intended for cleaning wounds.

Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound

Growing community of inventors

Dijon, France

Christelle Laurensou